HSK3486 (Cipepofol) Injectable Emulsion for Induction of General Anesthesia in Pediatric Subjects Undergoing Elective Surgery

ConditionGeneral Anesthetic

Trial statusNot yet recruiting

Trial phasePhase 3

Trial typeInterventional

Biological sexAll

Age3-17

SponsorHaisco Pharmaceutical Group Co., Ltd.

About this trial

This multicenter, randomized, double-blinded, propofol-controlled Phase 3b study enrolls pediatric subjects aged 3-17 years undergoing elective surgery with endotracheal intubation. Its primary purpose is to evaluate whether cipepofol is non-inferior to propofol in success of induction of general anesthesia in pediatrics undergoing elective surgery.

Eligibility criteria

Qualifiers

None

Disqualifiers

1. Subjects whose surgery is emergent, or who need emergency treatment during the surgery, or who need transfusion based on the investigator's judgment.

Trial design

Treatments tested in this trial

HSK3486
propofol

Treatment groups

400 Participants

are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Haisco Pharmaceutical Group Co., Ltd.

Lead sponsor

Source ClinicalTrials.gov